Search results
Showing 1201 to 1215 of 1259 results for pathway
Hypertension case finding and optimal management and lipid optimal management
and management NICE-endorsed resources NHS England Statin intolerance pathway brings together multiple NICE guidance and technology...
Patients to receive medicines 3 to 6 months faster under 10-Year Health Plan
NICE and the Medicines and Healthcare products Regulatory Agency (MHRA) have described how the 10-Year Health Plan will lead to faster medicines access for patients in the NHS in England.
NICE Advice works closely with our system partners and industry to drive innovation into the hands of health and care professionals, to enable best practice.
Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.
After four years of transformational leadership, NICE CEO Dr Sam Roberts will step down at the end of the year to support her children through a difficult time.
Agenda and papers of the NICE public board meeting on 11 December 2024
The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.
Tools for building or evaluating a medtech evidence base with NICE
Our role in the Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.
the public. It later became the Medicines and Prescribing Centre. NICE Pathways goes live In May we launched an online tool providing...
Access free webinars and paid-for masterclasses.
Resources to help with NHS access, system engagement and understanding the therapeutic landscape.
NICE responds to publication of the government's Life Sciences Sector Plan
We welcome the publication of the government's Life Sciences Sector Plan, which sets out how NICE will ensure patients get faster, fairer access to transformative new medicines and life-changing healthtech, while supporting a thriving life sciences industry in the UK.
NICE provisionally recommends leadless implantable pacemaker in draft guidance
A procedure for people with slow heart rhythms could be used more widely after it was recommended for NHS use in draft guidance.
NICE's past research and projects